Damage associated molecular patterns in necrotic femoral head inhibit osteogenesis and promote fibrogenesis of mesenchymal stem cells

Bone ◽  
2022 ◽  
Vol 154 ◽  
pp. 116215
Author(s):  
Zhuo Deng ◽  
Yinshi Ren ◽  
Min Sung Park ◽  
Harry K.W. Kim
2016 ◽  
Vol 2016 ◽  
pp. 1-10 ◽  
Author(s):  
Markus Huber-Lang ◽  
Rebecca Wiegner ◽  
Lorenz Lampl ◽  
Rolf E. Brenner

Mesenchymal stem cells (MSCs) are multipotent cells that are considered indispensable in regeneration processes after tissue trauma. MSCs are recruited to damaged areas via several chemoattractant pathways where they function as “actors” in the healing process by the secretion of manifold pro- and anti-inflammatory, antimicrobial, pro- and anticoagulatory, and trophic/angiogenic factors, but also by proliferation and differentiation into the required cells. On the other hand, MSCs represent “targets” during the pathophysiological conditions after severe trauma, when excessively generated inflammatory mediators, complement activation factors, and damage- and pathogen-associated molecular patterns challenge MSCs and alter their functionality. This in turn leads to complement opsonization, lysis, clearance by macrophages, and reduced migratory and regenerative abilities which culminate in impaired tissue repair. We summarize relevant cellular and signaling mechanisms and provide an up-to-date overview about promising future therapeutic MSC strategies in the context of severe tissue trauma.


Orthopedics ◽  
2008 ◽  
Vol 31 (5) ◽  
pp. 444 ◽  
Author(s):  
Bai-Liang Wang ◽  
Wei Sun ◽  
Zhen-Cai Shi ◽  
Jin-Ning Lou ◽  
Nian-Fei Zhang ◽  
...  

Joints ◽  
2018 ◽  
Vol 06 (01) ◽  
pp. 016-022 ◽  
Author(s):  
Riccardo D'Ambrosi ◽  
Elena Biancardi ◽  
Giulia Massari ◽  
Vincenza Ragone ◽  
Renato Facchini

Purpose The aim of this study was to report the rate of survivorship in patients with osteonecrosis of the femoral head treated with core decompression in association with mesenchymal stem cells (MSCs) implantation, platelet-rich plasma (PRP) injection, and synthetic bone graft. Methods We evaluated 24 hips in 16 patients, according to Ficat classification, treated by core decompression, injection of PRP and MSCs, and backfilling of the core tract with synthetic bone graft. Survivorship was estimated using Kaplan–Meier curves. Results The survivorship of core decompression in association with the procedure is 50% at 75 months of follow-up. The survival rate was 80% for patients in early stage and 28.6% for patients in advanced stage at 75 months. When we compared Kaplan–Meier survival curves of patients in stage III + IV and patients in stage I + II, we noticed that the survival functions are statistically different (p < 0.05, log-rank test), particularly in stage I + II where we had a greater surviving core decompression, in comparison to patients in stage III + IV. Conclusion This technique is safe and good preliminary results were obtained in patients with early stages of the disease with no reported complications. Level of Evidence Level IV, therapeutic case series.


Sign in / Sign up

Export Citation Format

Share Document